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Abstract: The aim of this study was to fabricate and characterize acellular porcine pericardium that can be used to patch cardiovascular
repair. Porcine pericardial tissues were treated with 10 mM Tris-HCl and sodium dodecyl sulfate (SDS) at different concentrations and
time intervals. The optimal decellularization protocol was determined according to elimination of cellular components and DNA via
histology and DNA quantification, respectively. There were no significant changes in stress and fracture strain after decellularization.
Liquid extracts from the decellularized pericardium caused no cytotoxicity towards human fibroblasts, were capable of supporting
an appropriate attachment of human endothelial progenitor cells, and did not cause a local inflammatory effect after 30 days of
transplantation in mice.
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1. Introduction
Cardiovascular diseases remain the leading cause of
death for both men and women around the world.
Such diseases killed approximately 17.5 million people
in 2012 (Mozaffarian et al., 2012). For patients, taking
medication can help alleviate symptoms, but there are
several possible side effects associated with medicine.
Based on the fact that it is more beneficial to treat the
root cause by repairing injured tissues, many studies
have focused on the manufacture of new patch materials
with potential advantages for heart and vascular repairs.
There are two main categories of materials that have been
clinically used in cardiovascular patching applications,
involving engineered tissues and synthetic materials.
Composite grafts provide numerous benefits, including
strength and durability (Venkatraman et al., 2008; Nelson
et al., 2011) but carry risks of infection, thrombogenicity,
calcification, and foreign body reaction as the well-known
limitations (Kannan et al., 2005; Lam and Wu, 2012). The
other potential choice for cardiovascular operations is
xenogeneic tissues. In terms of cardiovascular patching,
bovine pericardium, with the advantage of ready
availability, excellent biocompatibility, and a low rate of

infection, has been developed and tested in preclinical and
clinical studies (Pires et al., 1999; Biasi et al., 2002; Kim et
al., 2012). Porcine pericardial tissues with similar adequate
biological and mechanical properties (Gauvin et al., 2013)
have also recently been of great interest for cardiovascular
transplantation. A previous report suggested that due to the
structure and cross-linking of collagen bundles in porcine
pericardium, it might be regarded as a suitable alternative
to bovine pericardium for cardiovascular disease treatment
(Gauvin et al., 2013). Studies have established that, in
xenotransplantation, xenogeneic antigens may contribute
to both in vitro compatibility problems and in vivo
immune-mediated rejection of tissue (Auchincloss and
Sachs, 1998; Cascalho and Platt, 2001; Byrne and McGregor,
2012). In order to overcome several host immune barriers,
animal tissues such as porcine pericardia must undergo
decellularization before application in patients. Numerous
methods of decellularization, including physical,
chemical, and enzymatic treatments, have been developed
for the complete elimination of cellular components and
the preservation of the pericardial extracellular matrix
(ECM). However, it has been noted that almost all current
decellularization processes for porcine pericardia have
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negative effects on the mechanical and biological
properties of the ECM. In the present study, we aim to
establish an efficient decellularization procedure for native
porcine pericardia without causing alterations to the
ECM structure and properties. The acellular pericardium
is expected to be an ideal patch for cardiovascular tissue
engineering.
2. Materials and methods
2.1. Decellularization of porcine pericardium
Porcine pericardial sacs collected at a local slaughterhouse
were stored in cold 1X phosphate buffer saline (PBS, Gibco)
and transported to the laboratory. They were dissected to
remove external fat, washed thoroughly with PBS and
sectioned into small strips (2 × 2 cm). Pericardial strips
were treated in 10 mM Tris-HCl (Merck, USA) for 8 h and
divided into 9 groups to be treated with sodium dodecyl
sulfate (SDS, Sigma, USA) at different concentrations
and time intervals (Table 1). Finally, all specimens were
rinsed for 90 min in PBS to remove residual chemicals
and cellular remnants. All steps were carried out at room
temperature under continuous shaking at 80 rpm.
2.2. Histological analysis
Native and treated pericardial strips were fixed with 10%
formalin at 4 °C for 24 h. They were dehydrated stepwise using ethanol, immersed in xylene, and embedded
in paraffin. The paraffin sections were cut at 4 µm,
deparaffinized, and stained with hematoxylin and eosin
(H&E). Images were taken using an Olympus CKX-RCD
microscope (Tokyo, Japan) equipped with a DP2-BSW
microscope digital camera.
2.3. Evaluation of residual DNA
Pericardial strips were cut into small pieces and digested
with 100 ng/mL Proteinase K (Sigma, USA) at 37 °C until
no visible fragments remained. The digested samples were
then centrifuged at 13,000 rpm for 30 min. Afterwards,
the supernatants were purified with phenol–chloroform–
isoamyl alcohol (25:24:1) followed by centrifugation at
13,000 rpm for 30 min. Finally, the DNA pellets were
washed with 70% ethanol (Merck, USA) and dried by
air. The DNA contents were quantified by measuring
Table 1. Experimental sample groups treated with defined
concentrations of SDS for defined incubation periods.
Incubation time
SDS concentration

6h

12 h

24 h

0.1%

0.1–6

0.1–12

0.1–24

0.3%

0.3–6

0.3–12

0.3–24

0.5%

0.5–6

0.5–12

0.5–24
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absorbance at 260/280 nm in a Beckman Coulter DTX
880 Multimode Detector spectrophotometer (Fullerton,
CA, USA).
2.4. Mechanical testing
Strips of pericardium (5 × 2 cm) were prepared and treated
with Tris-HCl and SDS as described earlier. The strips
were mounted into holders and mechanically examined
for tensile strength and fracture behavior by extending to
fracture at an extension rate of 50 mm/min as described
previously (Sung et al., 1999). The mechanical testing was
conducted in an EZ50 universal testing machine (Lloyd
Instruments, UK) equipped with NEXYGENPlus material
test and data analysis software. The native tissues were
used as a control group.
2.5. Extract cytotoxicity assay
The cytotoxicity of decellularized pericardia (dP) was
analyzed using an extract test in accordance with ISO
10993/5. Human skin fibroblasts were used for the
cytotoxicity assay. The cells were grown in culture medium
(Dulbecco’s Modified Eagle Medium: Nutrient Mixture
F-12 (DMEM/F12, Sigma, USA) supplemented with
10% fetal bovine serum (FBS, Sigma, USA), 100 µg/mL
streptomycin (Sigma, USA), and 100 UI/mL penicillin
(Sigma, USA). Following ISO 10993/5, fibroblasts were
harvested at passage 4 and replated onto a 96-well plate
(4 × 103 cell per well). The cells were cultured for 24 h.
Meanwhile, the dP was incubated in a culture medium (6
cm2 per mL) at 37 °C for 24 h. After incubation, the culture
medium was separated and used as a full liquid extract. In
the cytotoxicity assay, the fibroblasts were incubated with
the liquid extract of the dP at 37 °C for 24 h. The culture
medium alone and a liquid extract of latex gloves (Baek
et al., 2005) were used as blank and positive controls,
respectively. After incubation for 24 h, the liquid extracts
were replaced with culture medium containing 0.5 mg/mL
MTT (Sigma, USA) and cultured for another 4 h. After
the medium was removed, 100 µL of dimethyl sulfoxide
(DMSO, Sigma, USA) was added to each well. Absorbance
at 575 nm was determined using a spectrophotometer
(Perkin, USA). Relative growth rate (RGR) was calculated
on OD575 values according to the ISO 10993/5 protocol as
RGR (%) = (ODtest group/ODblank group) × 100. If the RGR value
decreased by more than 30%, the liquid extract would be
considered to cause a cytotoxic effect (ISO 10993/5).
2.6. In vitro cell attachment assay
Decellularized pericardia were cut into square strips (1 ×
1 cm) and individually placed into the wells of agarosecoated 4-well plates. The coatings were prepared by adding
200 µL of 1% sterile molten agarose to each well. Human
endothelial progenitor cells (hEPCs) were then seeded at a
density of 104 cells per pericardium and allowed to adhere
for 1 h. The attachment and morphology of the hEPCs on
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the pericardial tissues were observed at 24 h by scanning
electron microscope (SEM).
2.7. Mouse subcutaneous implantation
The experiments were conducted in accordance with
the National Institutes of Health guidelines for the care
and use of laboratory animals (NIH Publication No.
85–23 Rev. 1985). The animal experiment protocol was
approved by the Animal Care and Use Committee of
the University of Science in Ho Chi Minh City, Vietnam
(Registration No. 03/15-010-00). In order to observe the
biocompatibility of the decellularized pericardia in vivo,
dP was implanted into the dorsum of mice (Mus musculus
var. albino, male, 6–8 weeks old, 25–30 g). Nine mice were
divided into three groups including one test group (dP)
and two control groups, one using native pericardia (nP)
and the other using skin incision without implantation.
Each pericardium sample was prepared as approximately
0.5 × 0.5 cm2 and sterilized with a dose of 25 kGy gamma
irradiation. Subcutaneous transplantation was carried out
under aseptic conditions. After 30 days, the mice were
euthanized. The implanted samples were obtained and
fixed in 10% formalin for histology (H&E staining).
2.8. Statistical analysis
All quantitative data are expressed as means ± standard
deviations. Statistical analyses were conducted using Prism
5 (GraphPad Software, Inc., San Diego, CA). Student’s t
test was used to analyze the differences between groups.
P values less than 0.05 were considered to be statistically
significant.
3. Results
3.1. Morphology and histology
Pericardial strips were treated in 10 mM Tris-HCl and
SDS at different concentrations and time intervals (Table
1). The pericardium is a tough and flexible membrane that

A

surrounds the heart. The pericardial strips treated with
0.1% SDS had a well-preserved appearance (Figure 1A),
whereas treating with 0.3% and 0.5% SDS made them stiff
and swollen compared with native pericardium, and this
was clearly observed for all indicated time intervals (Figure
1B). Therefore, 0.1% SDS, rather than 0.3% or 0.5% SDS, is
suitable to apply for decellularization of pericardium.
H&E staining revealed the underlying structure of the
native pericardial tissue, in which extracellular fibers were
stained pink, and nuclei were stained purple, indicating
the remaining cells (Figure 2A, arrows). Strips treated with
0.1% SDS showed no cells, and the three treated groups,
0.1–6 (Figure 2B), 0.1–12 (Figure 2C) and 0.1–24 (Figure
2D), did not differ microscopically. Moreover, the structure
of the extracellular fibers of the treated samples retained a
lamellar arrangement, similar to native pericardium.
3.2. DNA quantification
DNA quantification was done to determine the level of
elimination of cellular debris from the decellularized
samples. Native pericardial tissue with complete cellular
contents had a DNA amount as high as 445.3 ± 17.4 ng
per mg dry weight (Table 2). The DNA contents of the
pericardia specimens treated with 0.1% SDS for 12 and 24
h were significantly reduced to less than 50 ng per mg dry
weight (Figure 3). Taken together, 0.1% SDS applied for 12
h was the most effective approach for decellularization of
porcine pericardia.
3.3. Mechanical properties
Native and decellularized pericardial samples (0.1–12)
were tested for maximal stress (Figure 4) and fracture strain
(Figure 5). The mean maximal stress and fracture strain of
the decellularized samples were not different from those of
native pericardial samples (P > 0.05). This suggested that
the decellularization process had a minimal effect on the
mechanical properties of the pericardial samples.

B

Figure 1. Representative macroscopic appearance of treated pericardial strips. 1A. Pericardial strips treated with 0.1%
SDS. 1B. Pericardial strips treated with either 0.3% or 0.5% SDS.
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Figure 2. H&E staining of pericardial samples. 2A. Native samples. 2B. 0.1% SDS at 6 h incubation time. 2C. 0.1% SDS at 12
h. 2D. 0.1% SDS at 24 h. Cell configuration in native tissue (black arrow). 40× magnification.

3.4. Cytotoxicity assay
The morphology of the human fibroblasts after being treated
with liquid extracts is shown in Figure 6. The fibroblasts
have elongated shapes (Figure 6A), which remained
unchanged after 24 h of incubation in culture medium
(Figure 6B). The liquid extract from the decellularized
samples had no effect on the cells, as indicated by their
normal cell morphology after incubation for 24 h (Figure

6C) and their RGR value, which was found to be as high
as the RGR value of the group treated with the culture
medium (Table 3). On the other hand, as expected, the
liquid extract from latex gloves (as the positive control)
caused cell cytotoxicity after incubation for 24 h. The cells
were dead and exhibited cellular shrinkage after treatment
(Figure 6D) as well as having an RGR value reduced more
than 50% (Table 3).

Table 2. The average amount of DNA per dry weight of native pericardia and pericardia
treated with 0.1% SDS for 6 h (0.1–6), 12 h (0.1–12), and 24 h (0.1–24) (ng/mg dry
weight). All values are expresses as mean ± SD (n = 3).
DNA (ng/mg dry weight)
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Native pericardia

0.1–6

0.1–12

0.1–24

445.30 ± 17.410

120.00 ± 5.003

40.63 ± 4.677

35.97 ± 4.643

20

*

F r ac t u r e s t r a i n (%)

400
300
200
*

ns

100
0

15

10

5

3.5. Cell attachment
hEPCs were used to examine cell attachment support of
the decellularized pericardium. The hEPCs were seeded
onto decellularized pericardial samples and visualized
using SEM. The SEM images revealed the morphology
of the hEPCs on the decellularized pericardium. The
hEPCs attached to the pericardial matrix and spread into
polygonal-rounded appearance after being cultured for 48
h (Figure 7, arrows).
3.6. Subcutaneous implantation of porcine pericardia in
mice
After the surgery, all mice recovered well with no signs
of distress or disease, and no deaths occurred. All of
the implanted decellularized (dP) and native pericardia
(nP) were explanted at the end of 30 days of study. It

ns

60

40

20

12
10.

nP

0

Figure 4. Tensile strength (MPa) of native and decellularized
pericardium. nP = native pericardium, 0.1–12 = decellularized
with 0.1% SDS for 12 h. Tensile strength was calculated as mean
± SD (n = 5). ns = not significant (P > 0.05).

12
0.

nP

124
0.

0.

0.

16

112

0

Figure 3. DNA quantification of pericardial samples (ng DNA
per mg dry weight). DNA content was calculated as mean ± SD
(n = 3). * = P < 0.05. ns = not significant (P > 0.05).

Tensile streng th (M P a )

ns

1-

500

nP

DNA co ntent (ng /mg dry weig ht)

TRAN et al. / Turk J Biol

Figure 5. Fracture strain (%) of native and decellularized
pericardium. nP = native pericardium, 0.1–12 = decellularized
with 0.1% SDS for 12 h. Fracture strain was calculated as mean ±
SD (n = 5). ns = not significant (P > 0.05).

was observed that the pericardia from both groups had
been surrounded by a thin fibrous capsule. H&E staining
showed the fibrous capsule and vascular proliferation
surrounding the nP; moreover, local inflammation was
recognized via infiltration of the inflammatory cells
(Figure 8A, red arrows). The explanted dP also showed
fibrous and vascular proliferation, but no inflammation
was detected (Figure 8B).
4. Discussion
Pericardial specimens were treated in Tris-HCl for 12
h, followed by submersion in SDS solution at three
concentrations (0.1%, 0.3%, and 0.5%) for three time
intervals (6, 12, and 24 h). The histological structures
as well as the physical and biological properties of
the treated samples were examined to determine the
optimal experimental group for the production of tissueengineered pericardia for use in cardiovascular patching
applications.
H&E staining as well as DNA determination
demonstrated that the decellularization procedure using
0.1% SDS for 12 h was effective at removing cellular
components while still preserving the ECM architecture
(Figures 2–4). It has been reported that the decellularization
of porcine aortic valve leaflets and bovine pericardium
using 0.1% SDS for 24 h resulted in the complete removal of
cellular contents (Booth et al., 2002; Gonçalves et al., 2005).
In one study done by Liao et al. (2008), after treatment
with different processes using Triton X-100, SDS, sodium
deoxycholate, MEGA 10, TnBP, CHAPS, and Tween
20, over a range of concentrations, analysis showed that
there were no cell nuclei present in the tissues after 24 h
of treatment with SDS (0.03%–1%). This study suggested
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Figure 6. Morphological appearance of human fibroblast cells in a cytotoxicity assay. 6A. Cell morphology after 24
reseeded. 6B. Cell morphology when incubated for 24 h in the culture medium. 6C. Cell morphology when incubated for
24 h in the sample extract. 6D. Cell morphology when incubated for 24 h in the latex extract. 10× magnification.

that protocols utilizing SDS were successful for leaflet
decellularization, and these methods are being further
studied to produce tissue-engineered solutions for clinical
implantation. Furthermore, the combination of 0.1% SDS
and a hypotonic Tris buffer (10 mM Tris, pH 8.0) resulted
in acellular tissue as well as preservation of the structural
and mechanical properties of porcine aortic heart valve
leaflets. The total time consumption for this established
protocol was 48 h. In our study, the optimal procedure for
porcine pericardial tissues was identified with SDS at the
same concentration (0.1%), but with a shorter time period
(12 h).

Previous studies on aortic valves have considered SDS
decellularization to be a gentle treatment to maintain
the major structural components of elastin and collagen
(Grauss et al., 2003; Liao et al., 2007). On the other hand,
several reports have demonstrated SDS to cause strong
structural alterations (Kasimir et al., 2003). It was also
noted that this ionic detergent tends to cause a decrease
in glycosaminoglycan (GAG) concentration and a loss
of collagen integrity (Funamoto et al., 2010; Crapo et al.,
2011; Dong et al., 2013). This controversial finding seems
to be a consequence of the different incubation times
and SDS concentrations used in the decellularization

Table 3. OD575 values and relative growth rates (%) of the three experimental groups.
All values are expressed as mean ± SD (n = 3).
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Culture medium

Pericardium extracts

Latex extracts

OD575

0.27 ± 0.01

0.33 ± 0.03

0.12 ± 0.01

RGR (%)

100

122.00 ± 0.16

46.13 ± 0.05
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Figure 7. SEM examination of the attachment of hEPCs (arrows)
on acellular pericardia. Scale bar corresponds to 10 µm.

procedure. Processes to decellularize bovine pericardia or
aortic valves using 0.1% SDS for 24 h and 48 h, as described
in previous studies (Booth et al., 2002; Gonçalves et al.,
2005; Liao et al., 2008) showed no negative effects on ECM
integrity. In contrast, higher concentrations of SDS (higher
than 0.5%) were reported to have adverse effects when
treating tissue for a period of time (Samouillan et al., 1999;
Zhou et al., 2010; Dong et al., 2013). In our study, we found
that using 0.1% SDS for 12 h was effective in reducing the
cellular components of porcine pericardia without any
negative effects on the structure of the pericardial collagen
fibrils. Furthermore, the average ultimate tensile strength
and percent deformation of the decellularized pericardia
showed that mechanical properties of the studied tissues

were well maintained. These results are in accordance
with previously reported data (Booth et al., 2002;
Gonçalves et al., 2005; Liao et al., 2008).
The most important feature of decellularized tissue
for clinical applications is biocompatibility. Before doing
transplantation in humans, the safety of the implant
materials must be considered seriously. Multiple studies
have established that residual SDS in the tissue causes
cytotoxicity (Bodnar et al., 1986; Rieder et al., 2004;
Mirsadraee et al., 2007). However, it was noted in our
previous study that no cytotoxic effects were observed
among normal cells treated with the decellularized
pericardial extract. The relative growth rate, at 122.00
± 0.16% (higher than the 70% recommended by ISO
10995/5), also suggested that the studied tissue might be
beneficial to cell proliferation. Another interesting result
was the degree of cell adhesion to treated pericardia, which
indicated that these pericardia had good biocompatibility
and could be used as in vivo biological patches. For the
in vivo study, the biocompatibility of cellular and acellular
porcine pericardia was evaluated subcutaneously in
mouse models. By and large, the ECM grafts exhibited
high stability and compatibility with the surrounding
tissues. On the basis of our results, we suggest that porcine
pericardial tissue decellularized with 0.1% SDS for 12 h
could be a potential material for further cardiovascular
patching applications.
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Figure 8. H&E staining. 8A. Native pericardium (nP). 8B. Decellularized pericardium (dP) implanted subcutaneously into mice after
30 days. F = fibrous capsule, red arrows = immune cells. 40× magnification.
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